Back to Index
Marie-Victoire Guillot-Sestier
Postdoctoral Scholar Fellowship Trainee
Zilkha Neurogenetic Institute
ZNI 321 1501 San Pablo Street Health Sciences Campus Los Angeles
+1 323 442 4801


Guillot-Sestier MV, Doty KR, Town T. Innate Immunity Fights Alzheimer's Disease. Trends Neurosci. 2015 Nov; 38(11):674-81. View in: PubMed

Doty KR, Guillot-Sestier MV, Town T. The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive? Brain Res. 2015 Aug 18; 1617:155-73. View in: PubMed

Guillot-Sestier MV, Doty KR, Gate D, Rodriguez J, Leung BP, Rezai-Zadeh K, Town T. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron. 2015 Feb 4; 85(3):534-48. View in: PubMed

Guillot-Sestier MV, Town T. Innate immunity in Alzheimer's disease: a complex affair. CNS Neurol Disord Drug Targets. 2013 Aug; 12(5):593-607. View in: PubMed

Breunig JJ, Guillot-Sestier MV, Town T. Brain injury, neuroinflammation and Alzheimer's disease. Front Aging Neurosci. 2013; 5:26. View in: PubMed

Mori T, Koyama N, Guillot-Sestier MV, Tan J, Town T. Ferulic acid is a nutraceutical ß-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice. PLoS One. 2013; 8(2):e55774. View in: PubMed

Guillot-Sestier MV, Checler F. Cellular prion and its catabolites in the brain: production and function. Curr Mol Med. 2012 Mar; 12(3):304-15. View in: PubMed

Guillot-Sestier MV, Sunyach C, Ferreira ST, Marzolo MP, Bauer C, Thevenet A, Checler F. a-Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid ß (Aß)-associated cell death. J Biol Chem. 2012 Feb 10; 287(7):5021-32. View in: PubMed

Guillot-Sestier MV, Checler F. a-Secretase-derived cleavage of cellular prion yields biologically active catabolites with distinct functions. Neurodegener Dis. 2012; 10(1-4):294-7. View in: PubMed

Cissé M, Duplan E, Guillot-Sestier MV, Rumigny J, Bauer C, Pagès G, Orzechowski HD, Slack BE, Checler F, Vincent B. The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein. J Biol Chem. 2011 Aug 19; 286(33):29192-206. View in: PubMed

Guillot-Sestier MV, Sunyach C, Druon C, Scarzello S, Checler F. The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J Biol Chem. 2009 Dec 18; 284(51):35973-86. View in: PubMed

Pardossi-Piquard R, Dunys J, Giaime E, Guillot-Sestier MV, St George-Hyslop P, Checler F, Alves da Costa C. p53-dependent control of cell death by nicastrin: lack of requirement for presenilin-dependent gamma-secretase complex. J Neurochem. 2009 Apr; 109(1):225-37. View in: PubMed

Dolcini V, Dunys J, Sevalle J, Chen F, Guillot-Sestier MV, St George-Hyslop P, Fraser PE, Checler F. TMP21 regulates Abeta production but does not affect caspase-3, p53, and neprilysin. Biochem Biophys Res Commun. 2008 Jun 20; 371(1):69-74. View in: PubMed

Vincent B, Cisse MA, Sunyach C, Guillot-Sestier MV, Checler F. Regulation of betaAPP and PrPc cleavage by alpha-secretase: mechanistic and therapeutic perspectives. Curr Alzheimer Res. 2008 Apr; 5(2):202-11. View in: PubMed

Powered bySC CTSI